Family planning uptake and its associated factors among women of reproductive age in Uganda: an insight from the Uganda Demographic and Health Survey 2016

Abstract

Despite the government efforts to reduce the high fertility levels and increase uptake of family planning services in Uganda, family planning use was still low at 30% which is the lowest in the East African region. This study was undertaken to determine the prevalence and factors associated with the uptake of family planning methods among women of reproductive age in Uganda. This is a community-based cross-sectional study that utilized secondary data from the Uganda Demographic and Health Survey (UDHS) of 2016. The survey data was downloaded from the Measure Demographic Health Survey website after data use permission was granted. Data was collected from a representative sample of women of the reproductive age group (15-49 years) from all the 15 regions in Uganda. A total of 19,088 eligible women were interviewed but interviews were completed with 18,506 women. Data analysis was performed using SPSS statistical software version 32.0 where univariable, bivariable, and multivariable analyses were conducted. The prevalence of family planning use was found to be 29.3% and that of modern contraceptive use was found to be 26.6%. Multivariable analysis showed higher odds of current family planning use among older women (40-44 years) (aOR=2.09, 95% CI: 1.40-3.12); women who had attained the secondary level of education (aOR=1.91, 95% CI: 1.32-2.76); those living in households with the highest wealth index (aOR=1.87, 95% CI: 1.29-2.72); and awareness of the availability of family planning methods (aOR=1.41, 95% CI: 1.17-1.72). In conclusion, the study found a low prevalence of current family planning use among women of reproductive age and this calls for more efforts toward the advancement of women’s education, awareness creation, designing policies to popularize use of FP among adolescents and young women, and socio-economic empowerment of women.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

"N/A"

Funding Statement

The research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The survey was approved by the Uganda National Council for Science and Technology (UNCST). Respondents were informed about the survey and informed consent was obtained from participants. The authors received the survey data from the USAID DHS program database after a request to download the dataset was granted. After data access was authorized, the authors of this study maintained the confidentiality of the dataset.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

留言 (0)

沒有登入
gif